Nanjing Leads Biolabs Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	421.69	372.54	247.52
Trading Asset Securities	30.02	166.18	100.13
Cash & Short-Term Investments	451.71	538.72	347.65
Cash Growth	-	54.96%	-
Other Current Assets	67.78	57.59	19.47
Total Current Assets	550.3	596.31	367.12
Property, Plant & Equipment	48.84	47.57	61.09
Other Long-Term Assets	30.94	25.57	19.27
Total Assets	630.63	669.44	447.48
Accounts Payable	0.96	3.52	0.22
Accrued Expenses	54.34	34.26	23.33
Current Portion of Long-Term Debt	280.17	255.21	61
Current Portion of Leases	7.36	5.72	4.31
Current Income Taxes Payable	0.58	0.78	0.9
Current Unearned Revenue	157.8	84.22	-
Other Current Liabilities	12.3	14.63	1,305
Total Current Liabilities	513.52	398.34	1,395
Long-Term Leases	12.03	5.55	1.78
Total Liabilities	525.76	403.88	1,396
Common Stock	156.5	156.5	17.02
Retained Earnings	-	-195.56	-982.76
Comprehensive Income & Other	-51.63	304.62	16.93
Shareholders' Equity	104.87	265.56	-948.81
Total Liabilities & Equity	630.63	669.44	447.48
Total Debt	299.56	266.48	67.09
Net Cash (Debt)	152.15	272.24	280.57
Net Cash Growth	-	-2.97%	-
Net Cash Per Share	0.98	1.81	1.94
Filing Date Shares Outstanding	156.5	156.5	144.85
Total Common Shares Outstanding	156.5	156.5	144.85
Working Capital	36.78	197.97	-1,027
Book Value Per Share	0.67	1.70	-6.55
Tangible Book Value	104.32	265.56	-948.81
Tangible Book Value Per Share	0.67	1.70	-6.55
Machinery	-	75.61	74.21
Construction In Progress	-	-	0.36
Leasehold Improvements	-	25.85	24.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.